Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative Anti-Inflammatory Drugs in Trabeculectomy
NCT00707421Phase 3Completed
- Sponsor
- UZ Leuven
- Start
- Jul 2005
- Primary completion
- May 2009
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ketorolac and fluorometholone in Glaucoma (3 arms), sponsored by UZ Leuven. Primary endpoints: Incidence of additional IOP-lowering procedures or postoperative medication at 24 months and Intraocular pressure evolution at 24 months. Started Jul 2005; status: completed.
02
Drugs
ketorolacfluorometholone
03
Conditions
Glaucoma
Beyond the preview
Go deeper on NCT00707421.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00707421.